FDA Approves Veklury as First Treatment for COVID-19 – Renal and Urology News

The FDA approved Veklury (remdesivir; Gilead Sciences) for the treatment of COVID-19 in patients aged ≥12 years (weighing ≥40kg) requiring hospitalization.

Read the full article here

Related Articles